Blood contact properties of ascorbyl chitosan
Source abstract
Abstract
Ascorbyl chitosan was synthesized by heating chitosan with ascorbic acid in isopropanol. The products were characterized by FTIR and C-13 NMR spectroscopies, SEM, and elemental analysis. Blood contact properties of ascorbyl chitosans were evaluated. The ascorbyl chitosans demonstrated to have increased lipid-lowering activity in comparison to chitosan alone upon contact with human blood serum in in vitro conditions. Furthermore, the total cholesterol/HDL ratio was improved towards the desirable ideal values after three hours contact with ascorbyl chitosan samples. The lipid-lowering activity increased with ascorbyl substitution. The inherent nonspecific adsorption capability of chitosan due to its chelating power with several different functional groups was exhibited by ascorbyl chitosans as well. This behavior was exemplified in a simultaneous decrease in the total iron values of the volunteers together with lower lipid levels. Furthermore, ascorbyl chitosans were observed to have less hemocompatibility but increased anticoagulant activity when compared to chitosan alone. Additional in vivo studies are necessary to support these results and to investigate further the advantages and disadvantages of these materials to prove their safety prior to clinical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Vitamin C and Antioxidants Research · Nanocomposite Films for Food Packaging · Vitamin K Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Eastern Mediterranean University, Famagusta, North Cyprus via Mersin 10, Turkey.
Department of Biological Sciences, Eastern Mediterranean University, Famagusta, North Cyprus via Mersin 10, Turkey.
Bio-Lab, Medical Laboratory, Famagusta, North Cyprus via Mersin 10, Turkey.
References (35)
Show source-provided references
1. Ishihara M, Fujita M, Kishimoto S, Hattori H, Kanatani Y. Chitosan-based systems for biopharmaceuticals: delivery, targeting and polymer therapeutics. Chichester: John Wiley; 2012. Chapter 6, Biological, chemical, and physical compatibility of chitosan and biopharmaceuticals; p. 93–106.10.1002/9781119962977.ch6 ↗
2. Muzzarelli RAA. Chitosan per os – from dietary supplement to drug carrier. Grottamare: Atec; 2000. Chapter 1, Recent results in the oral administration of chitosan; p. 3–40.
3. 10.1016/S0271-5317(98)00091-810.1016/S0271-5317(98)00091-8 ↗
4. 10.1007/s10126-005-0097-510.1007/s10126-005-0097-5 ↗
5. Muzzarelli RAA. Applications of chitin and chitosan. Switzerland: Technomic Publishing; 1997. Chapter 7, Chitosans as dietary food additives; p. 115–127.10.1201/9781003072812-10 ↗
6. 10.1016/j.progpolymsci.2011.02.00110.1016/j.progpolymsci.2011.02.001 ↗
7. 10.1016/j.yrtph.2009.09.01510.1016/j.yrtph.2009.09.015 ↗
8. 10.1177/08839115900050030510.1177/088391159000500305 ↗
9. Amiji M · Carbohydr. Polym · 1997 · 32 · 19310.1016/S0144-8617(97)00006-4 ↗
10. 10.1007/s10856-007-3243-y10.1007/s10856-007-3243-y ↗
11. 10.1016/S0144-8617(03)00076-610.1016/S0144-8617(03)00076-6 ↗
12. 10.1016/j.ijbiomac.2006.06.02110.1016/j.ijbiomac.2006.06.021 ↗
13. Janvikul W · J. Appl. Polym. Sci · 2006 · 102 · 44510.1002/app.24192 ↗
14. Fana L · Int. J. Biol. Macromol · 2012 · 50 · 3110.1016/j.ijbiomac.2011.09.024 ↗
15. 10.1016/0144-8617(87)90051-810.1016/0144-8617(87)90051-8 ↗
16. Tokura S, Itoyama M, Hiroshi S. Partially sulfated chitosan oligomers immobilized on chitosan for antithrombogenic medical goods. Jpn. Kokai Tokkyo Koho JP6389167.1988.
17. Malette WG · Ann. Thorac. Surg · 1986 · 36 · 5510.1016/S0003-4975(10)60649-2 ↗
18. Klokkevold PR · J. Oral Maxillofac. Surg · 1991 · 49 · 85810.1016/0278-2391(91)90017-G ↗
19. Furda I. Non absorbable Lipid Binder. United States patent US 4223023. 1980.
20. Furda I. Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan. United States patent US 573653. 1998.
21. 10.1271/bbb.57.143910.1271/bbb.57.1439 ↗
22. 10.1271/bbb.59.78610.1271/bbb.59.786 ↗
23. Trautwein EA · Nutr. Res · 1997 · 17 · 105310.1016/S0271-5317(97)00069-9 ↗
24. Xu G · Asia-Pac. J. Clin. Nutr · 2007 · 16 · 313
25. 10.1080/07315724.2008.1071967110.1080/07315724.2008.10719671 ↗
26. 10.1016/j.foodchem.2010.07.03910.1016/j.foodchem.2010.07.039 ↗
27. Muzzarelli RAA · Carbohydr. Polym · 2006 · 66 · 36310.1016/j.carbpol.2006.03.021 ↗
28. 10.1080/1040839920952757910.1080/10408399209527579 ↗
29. Xiaolin T · J. Appl. Polym. Sci · 2009 · 114 · 298610.1002/app.30918 ↗
30. Jennings CD · Proc. Soc. Exp. Biol. Med · 1988 · 189 · 1310.3181/00379727-189-42773 ↗
31. Sugano M · Nutr. Rep. Int · 1978 · 18 · 531
32. Mabuchi H · New Engl. J. Med · 1984 · 308 · 60910.1056/NEJM198303173081101 ↗
33. Gylling H · Eur. J. Clin. Pharmacol · 1989 · 37 · 11110.1007/BF00558216 ↗
34. Gylling H · Metabolism · 1991 · 40 · 3510.1016/0026-0495(91)90189-4 ↗
35. Yalinca Z · J. Appl. Polym. Sci · 2012 · 125 · 149310.1002/app.34911 ↗